Study to Analyse the Use of a Digital Platform for the Preparation and Follow-up of Patients With Scheduled Outpatients Colonoscopy
COLObs
An Observational Study of the Digital Platform Use for the Preparation and Monitoring of Patients With Scheduled Outpatient Colonoscopy
1 other identifier
observational
225
1 country
1
Brief Summary
The goal of this clinical trial investigation with device is to to analyze the use of the Caaring® digital platform for the preparation and follow-up of scheduled colonoscopy. Colonoscopy is a difficult procedure, and it is estimated that bowel preparation is inadequate in about 25% of patients. The main question it aims to answer is if the use of a digital platform (Caaring®) could be an effective tool for reducing the percentage of inadequate bowel preparations in patients with a scheduled colonoscopy. To this end, the application will provide precise instructions to patients. A prospective, single-center, observational study with software device: The recruitment phase is expected to last two months. Patients will be followed for one month after the colonoscopy and 14 days prior to it. Additionally, measuring patient experience and monitoring adverse effects after a colonoscopy are crucial to improving the safety of colonoscopies and the quality of healthcare, promoting higher quality colonoscopy services. For that to happen, participants must have sufficient technological skills to use a smartphone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2025
CompletedFirst Submitted
Initial submission to the registry
March 31, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJune 15, 2025
June 1, 2025
4 months
March 31, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients scheduled colonoscopy who have an adequate bowel preparation.
Percentage of colonoscopies with adequate bowel preparation defined as having a total Boston Bowel Preparation Scale (BBPS) score greater than or equal of 6 and BBPS score for per colon segment ≥2.
Day 0, (Colonoscopy Day)
Secondary Outcomes (16)
Active Patient Rate
Day -14 (14 days before the colonoscopy)
Patients with section completed: Treatments
Day -14 (14 days before the colonoscopy)
Patients with section completed: Pick up the bowel preparation
Day -10 (10 days before colonoscopy)
Patients with section completed: Colonoscopy Preparation Solution (laxative).
Day 2 (2 days after colonoscopy)
Patients with section completed: Procedure satisfaction questionnaire
Day 3 (3 days after colonoscopy)
- +11 more secondary outcomes
Eligibility Criteria
All patients from the Hospital Clínic in Barcelona diagnosed with a scheduled colonoscopy who meet the selection criteria and sign the informed consent will be included.
You may qualify if:
- Age 18 or older.
- Signed informed consent.
- Patients scheduled for outpatient colonoscopy.
- Patients able to complete the study questionnaires.
- Patients who regularly use a smartphone
You may not qualify if:
- Patients enrolled in the population-based colorectal cancer screening program with a positive fecal occult blood test.
- Minors or elderly patients (over 80 years of age).
- Patients with prior colorectal surgery.
- Patients who, in the opinion of the researcher, will not be able to commit to follow-up or lack adequate technological skills.
- Inability to provide adequate informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Persei Vivariumlead
- Effice Servicios Para la Investigacion S.L.collaborator
Study Sites (1)
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2025
First Posted
April 8, 2025
Study Start
March 13, 2025
Primary Completion
July 1, 2025
Study Completion
August 1, 2025
Last Updated
June 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share